CANESTEN POWDER 1 %
TOLNAFTATE : 1 % · DIN 02240064 · BAYER INC
Health Canada status: APPROVED
What is CANESTEN POWDER?
CANESTEN POWDER 1 % contains TOLNAFTATE : 1 %. It is listed in the Health Canada Drug Product Database under DIN 02240064, held by BAYER INC, supplied as POWDER for TOPICAL administration. Health Canada currently lists it as approved, status dated 21-Apr-1999. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02240064 |
|---|---|
| Brand name | CANESTEN POWDER |
| Generic / active ingredient | TOLNAFTATE : 1 % |
| Manufacturer | BAYER INC |
| Strength | 1 % |
| Dosage form | POWDER |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D01AE18 TOLNAFTATE |
| AHFS class | 84:04.08.40 |
| Biosimilar | No |
| Health Canada status | APPROVED |
| Status date | 21-Apr-1999 |
What can be used instead?
Other Canadian products sharing ATC code D01AE18 TOLNAFTATE. 11 of 52 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| DR. SCHOLL'S ATHLETE'S FOOT SPRAY POWDER | 1 % | POWDER ; AEROSOL | SCHOLL'S WELLNESS COMPANY | MARKETED | DIN 01919245 |
| FLEXITOL MEDICATED ANTI-FUNGAL CREAM | 1 % | CREAM | LACORIUM HEALTH INTERNATIONAL PTY LTD. | MARKETED | DIN 02295873 |
| FOOTRENEW | 1 % | SOLUTION | NAILRENEW CORP. | MARKETED | DIN 02527723 |
| FORMULA 3 | 1 % | SOLUTION | THE TETRA CORPORATION | MARKETED | DIN 02413760 |
| ODOR-EATERS | 1 % | AEROSOL | BLISTEX CORPORATION | MARKETED | DIN 02244777 |
| TINACTIN | 1 % | CREAM | BAYER INC | MARKETED | DIN 00576034 |
| TINACTIN AEROSOL POWDER | 1 % | POWDER ; AEROSOL | BAYER INC | MARKETED | DIN 00576050 |
| TINACTIN CHILL DEODORANT POWDER SPRAY | 1 % | AEROSOL ; POWDER | BAYER INC | MARKETED | DIN 02319276 |
| TINACTIN CHILL LIQUID SPRAY | 1 % | AEROSOL | BAYER INC | MARKETED | DIN 02319314 |
| TINACTIN POWDER | 1 % | POWDER | BAYER INC | MARKETED | DIN 00576042 |
Who else supplies TOLNAFTATE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. TOLNAFTATE appears in 663 registered pack listings across 2 markets, published on 2 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
This product is approved by Health Canada but not yet marketed in Canada, so there is no Canadian supply to draw on today. Nexara can tell you whether it has been launched, and can look at supply from other markets where a Canadian pack is not required or where importation is permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.